| Emily Pattillo, PT, DPT | |
|
2351 Indian Wells Rd, Alamogordo, NM 88310-4607 | |
| (575) 437-3351 | |
| Not Available |
| Full Name | Emily Pattillo |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 2024 Years |
| Location | 2351 Indian Wells Rd, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073139341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT5716 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alamogordo Physical Therapy And Wellness Center, Inc | 8729998794 | 9 |
News Archive
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.
arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.
› Verified 1 days ago
| Provider Name | Alamogordo Physical Therapy & Wellness Center, Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1043225493 PECOS PAC ID: 8729998794 Enrollment ID: O20090416000052 |
News Archive
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.
arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.
› Verified 1 days ago
| Provider Name | Carlsbad Physical Therapy & Wellness Center Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1841205200 PECOS PAC ID: 6507836251 Enrollment ID: O20121011000580 |
News Archive
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.
arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.
› Verified 1 days ago
| Provider Name | Artesia Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1033124490 PECOS PAC ID: 3375625478 Enrollment ID: O20140905000396 |
News Archive
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.
arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Pattillo, PT, DPT Po Box 2860, Alamogordo, NM 88311-2860 Ph: (575) 437-3351 | Emily Pattillo, PT, DPT 2351 Indian Wells Rd, Alamogordo, NM 88310-4607 Ph: (575) 437-3351 |
News Archive
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.
arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.
› Verified 1 days ago
Chris Kotter, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2351 Indian Wells, Alamogordo, NM 88310 Phone: 575-439-1397 | |
Oliver C Nuique, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2351 Indian Wells Rd, Alamogordo, NM 88310 Phone: 575-437-3351 Fax: 575-437-2622 | |
Matthew Anthony Larkin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-446-7532 | |
Alamogordo Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 2351 Indian Wells, Alamogordo, NM 88310 Phone: 575-439-1397 Fax: 575-437-2622 | |
Zachary Carr, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2351 Indian Wells Rd, Alamogordo, NM 88310 Phone: 575-437-3351 Fax: 575-437-2622 | |
Scott Nufer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 10th St, A, Alamogordo, NM 88310 Phone: 575-439-9878 Fax: 575-439-9876 |